Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Prospective identification of tumorigenic breast cancer cells
2003 Standout
The 2017 hormone therapy position statement of The North American Menopause Society
2017
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 Standout
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Diffusion of innovations
2003 Standout
Telehealth and patient satisfaction: a systematic review and narrative analysis
2017 Standout
Breast cancer
2019 Standout
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
2000
Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
2002
Frequency of Breast Cancer Attributable to <EMPH TYPE="ITAL">BRCA1</EMPH> in a Population-Based Series of American Women
1998
Guidelines for a genetic risk based approach to advising women with a family history of breast cancer
2000
Osteoporosis
2019 Standout
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
1998
Microsatellite Instability in Colorectal Cancer
2010 Standout
Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer
2013
Lay Attitudes toward Genetic Testing for Susceptibility to Inherited Diseases
2001
The BRCA1 C-terminal domain: structure and function
2000
Genetic counseling forBRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process
2005
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 Standout
BRCA2 T2722R Is a Deleterious Allele That Causes Exon Skipping
2002
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
2005
Breast and Ovarian Cancer
2003
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
2005 StandoutNature
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2
2001
Machine learning applications in cancer prognosis and prediction
2014 Standout
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Colorectal cancer
2013 Standout
Intronic variants inBRCA1andBRCA2that affect RNA splicing can be reliably selected by splice-site prediction programs
2008
Hereditary cancer risk notification and testing: how interested is the general population?
1997
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Genetics of breast cancer: a topic in evolution
2015
BRCA1/2testing in hereditary breast and ovarian cancer families: Effectiveness of problem‐solving training as a counseling intervention
2004
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Repair of Endogenous DNA Damage
2000 StandoutNobel
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Provision of genetic services in Europe: current practices and issues
2003
Patients’ Resistance to Risk Information in Genetic Counseling for BRCA1/2
2005
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
2004
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
2005
Male breast cancer
2006 Standout
Racial Differences in the Use of <EMPH>BRCA1/2</EMPH> Testing Among Women With a Family History of Breast or Ovarian Cancer
2005
Assessing the Risk of Breast Cancer
2000
Prediction of MLH1 and MSH2 Mutations in Lynch Syndrome
2006
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Hereditary Colorectal Cancer
2003 Standout
The Role of BRCA1 in the Cellular Response to Chemotherapy
2004
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review
2016
Genetic and Hormonal Risk Factors in Breast Cancer
2000
Synthetic lethality: the road to novel therapies for breast cancer
2016
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women
2006
Early adoption of BRCA1/2 testing: Who and why
2003
Hereditary and Familial Colon Cancer
2010
Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1
2001
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Second cancers after conservative surgery and radiation for stages I–II breast cancer: identifying a subset of women at increased risk
2001
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Recent advances in breast cancer biology
1999
Genomic imprinting: parental influence on the genome
2001 Standout
Growth effects of uniparental disomies and the conflict theory of genomic imprinting
1997
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Oestrogen exposure and breast cancer risk
2003
Interest in BRCA1/2 Testing in a Primary Care Population
2002
Cancer of the Ovary
2004 Standout
Racial differences in genetic factors associated with breast cancer
2003
Healthy Women with a Family History of Breast Cancer: Impact of a Tailored Genetic Counseling Intervention on Risk Perception, Knowledge, and Menopausal Therapy Decision Making
2006
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Genetically Engineered Rodent Models of Mammary Gland Carcinogenesis: An Overview
2001
Artificial Intelligence in Surgery: Promises and Perils
2018 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
2015
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Ovarian cancer statistics, 2018
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Research and Practice Opportunities at the Intersection of Health Education, Health Behavior, and Genomics
2005
Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations
2000
Psychosocial Genetic Counseling in the Post‐Nondirective Era: A Point of View
2003
Risk Information Exposure and Direct-to-Consumer Genetic Testing for BRCA Mutations among Women with a Personal or Family History of Breast or Ovarian Cancer
2009
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
2017
Characterization ofBRCA1andBRCA2Mutations in a Large United States Sample
2006
STERILIZED in the Name of Public Health
2005 Standout
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.
2002
The Association between Race and Attitudes about Predictive Genetic Testing
2004
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
2001
Breast carcinoma in carriers of BRCA1 or BRCA2 mutations
1998
Anisomastia Associated with Interstitial Duplication of Chromosome 16, Mental Retardation, Obesity, Dysmorphic Facies, and Digital Anomalies: Molecular Mapping of a New Syndrome by Fluorescent in Situ Hybridization and Microsatellites to 16q13 (D16S419-D16S503)*
2000
Recent advances in artificial intelligence and machine learning for nonlinear relationship analysis and process control in drinking water treatment: A review
2020 Standout
Applications of machine learning in cancer prediction and prognosis.
2007
Applications of Machine Learning in Cancer Prediction and Prognosis
2006
Breast Cancer in Men
2002 Standout
The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations
1998
Genetic Testing for Cancer Predisposition
2001
Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography
2014 Standout
Works of Jill E. Stopfer being referenced
Common Familial Colorectal Cancer Linked to Chromosome 7q31: A Genome-Wide Analysis
2008
The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families
2008
Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer
2012
Characterization of Two Novel BRCA1 Germ-Line Mutations Involving Splice Donor Sites
2004
Accuracy of Cancer Family Histories: Comparison of Two Breast Cancer Syndromes
2004
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy
2011
Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16
1996
BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
1997
Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study
2016
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer
2014
Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy
2008
Genetic counseling and clinical cancer genetics services
2000
Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk
2002
Role of the genetic counselor in familial cancer.
1996
BRCA1 and BRCA2 Mutation Frequency in Women Evaluated in a Breast Cancer Risk Evaluation Clinic
2002
Anticipated Versus Actual Emotional Reactions to Disclosure of Results of Genetic Tests for Cancer Susceptibility: Findings From p53 and BRCA1 Testing Programs
2000
Application of Breast Cancer Risk Prediction Models in Clinical Practice
2003
Factors associated with decisions about clinical BRCA1/2 testing.
2000
Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing
1996